Finance

Lists
Why is HYL down 5,61%?
Dive Deeper
HYL:EBR
Hyloris Pharmaceuticals SA
€4,04
-5,61%
(-0,24) 1D
19 Okt., 17:22:26 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HYL...
Open
€4,11
High
€4,25
Low
€4,02
Mkt. cap
113,12 m
Avg. vol.
5,76 k
Volume
2,20 k
52-wk high
€8,40
52-wk low
€3,38
EPS
-€0,17
Shares outstanding
28,00 m
No. of employees
54
Open
€4,11
High
€4,25
Low
€4,02
Mkt. cap
113,12 m
Avg. vol.
5,76 k
Volume
2,20 k
52-wk high
€8,40
52-wk low
€3,38
EPS
-€0,17
Shares outstanding
28,00 m
No. of employees
54
News stories
From web sources and news partners
About Hyloris Pharmaceuticals SA
CEOStijn Van Rompay
Employees54
Founded2012
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
2,30 m
2,30 m
2,61 m
2,61 m
Cost of goods sold
125,50 k
125,50 k
149,00 k
149,00 k
Cost of revenue
125,50 k
125,50 k
149,00 k
149,00 k
Research and development expenses
3,15 m
3,15 m
2,08 m
2,08 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,34 m
1,34 m
1,26 m
1,26 m
Operating expense
4,49 m
4,49 m
3,17 m
3,17 m
Total operating expenses
4,61 m
4,61 m
3,32 m
3,32 m
Operating income
-2,31 m
-2,31 m
-707,00 k
-707,00 k
Other non operating income
87,00 k
87,00 k
-3,00 k
-3,00 k
EBT including unusual items
-1,50 m
-1,50 m
-937,50 k
-937,50 k
EBT excluding unusual items
-2,20 m
-2,20 m
-700,50 k
-700,50 k
Income tax expense
-106,00 k
-106,00 k
-
-
Effective tax rate
7,09%
7,09%
-
-
Other operating expenses
-6,50 k
-6,50 k
-173,50 k
-173,50 k
Net income
-1,39 m
-1,39 m
-937,50 k
-937,50 k
Net profit margin
-60,41%
-60,41%
-35,87%
-35,87%
Earnings per share
-
-
-
-
Interest and investment income
271,00 k
271,00 k
42,00 k
42,00 k
Interest expense
-14,00 k
-14,00 k
-21,50 k
-21,50 k
Net interest expenses
257,00 k
257,00 k
20,50 k
20,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-2,00 m
-2,00 m
-518,50 k
-518,50 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme